Загрузка...
Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first‐line oxaliplatin‐based treatment
The conventional first‐line chemotherapy for metastatic colorectal cancer (mCRC) consists of fluorouracil (5‐FU) in combination with either oxaliplatin or irinotecan. We have explored microRNAs (miRNAs) in plasma as potential predictive markers to oxaliplatin‐based chemotherapy. The expression of 74...
Сохранить в:
| Опубликовано в: : | Mol Oncol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528512/ https://ncbi.nlm.nih.gov/pubmed/24119443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2013.09.001 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|